THE PHARMACOLOGY OF NEUROSTEROIDOGENESIS

被引:81
作者
COSTA, E
AUTA, J
GUIDOTTI, A
KORNEYEV, A
ROMEO, E
机构
[1] Fidia Georgetown Institute for the Neurosciences, Georgetown University Medical School, Washington, DC 20007, 3900 Reservoir Road, N.W
关键词
D O I
10.1016/0960-0760(94)90284-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
In adrenal cortex and other steroidogenic tissues including glial cells, the conversion of cholesterol into pregnenolone is catalyzed by the cytochrome P450(sec) located in the inner mitochondrial membrane. A complex mechanism operative in regulating cholesterol access to P450(sec) limits the rate of pregnenolone biosynthesis. Participating in this mechanism are DBI (diazepam binding inhibitor), an endogenous peptide that is highly expressed in steroidogenic cells and some of the DBI processing products including DBI 17-50 (TTN). DBI and TTN activate steroidogenesis by binding to a specific receptor located in the outer mitochondrial membrane, termed mitochondrial DBI receptor complex (MDRC). MDRC is a hetero-oligometric protein: only the subunit that includes the DBI and benzodiazepine (BZD) recognition sites has been cloned. Several 2-aryl-3-indoleacetamide derivatives (FGIN-1-X) with highly selective affinity (nM) for MDRC were synthesized which can stimulate steroidogenesis in mitochondrial preparations. These compounds stimulate adrenal cortex steroidogenesis in hypophysectomized rats but not in intact animals. Moreover, this steroidogenesis in inhibited by the isoquinoline carboxamide derivative PK 11195, a specific high affinity ligand for MDRC with a low intrinsic steroidogenic activity. Some of the FGIN-1-X derivatives stimulate brain pregnenolone accumulation in adrenalectomized-castrated rats. The FGIN-1-X derivatives that increase brain pregnenolone content, elicit antineophobic activity and antagonize punished behavior in the Vogel conflict test in rats. These actions of FGIN-1-X are resistant to inhibition by flumazenil, a specific inhibitor of BZD action in GABAA receptors but are antagonized by PK 11195, a specific blocker of the steroidogenesis activation via MDRC stimulation. It is postulated that the pharmacological action of FGIN-1-X depends on a positive modulation of the GABA action on GABA(A) receptors mediated by the stimulation of brain neurosteroid production.
引用
收藏
页码:385 / 389
页数:5
相关论文
共 28 条
[1]
ANHOLT RRH, 1986, J BIOL CHEM, V261, P576
[2]
AUTA J, 1993, J PHARMACOL EXP THER, V265, P649
[3]
NEUROSTEROIDS - A NEW BRAIN-FUNCTION [J].
BAULIEU, EE ;
ROBEL, P .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (03) :395-403
[4]
BORMANN J, 1985, REGUL PEPTIDES, P33
[5]
SPECIFIC BENZODIAZEPINE RECEPTORS IN RAT-BRAIN CHARACTERIZED BY HIGH-AFFINITY [DIAZEPAM-H-3] BINDING - (AFFINITY BINDING DIAZEPAM ANXIOLYTIC ACTIVITY BRAIN MEMBRANES REGIONAL DISTRIBUTION) [J].
BRAESTRUP, C ;
SQUIRES, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (09) :3805-3809
[6]
DIAZEPAM-BINDING INHIBITOR (DBI)-PROCESSING PRODUCTS, ACTING AT THE MITOCHONDRIAL DBI RECEPTOR, MEDIATE ADRENOCORTICOTROPIC HORMONE-INDUCED STEROIDOGENESIS IN RAT ADRENAL-GLAND [J].
CAVALLARO, S ;
KORNEYEV, A ;
GUIDOTTI, A ;
COSTA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10598-10602
[7]
STEREOSELECTIVE INHIBITION OF THE BINDING OF [H-3] PK 11195 TO PERIPHERAL-TYPE BENZODIAZEPINE BINDING-SITES BY A QUINOLINEPROPANAMIDE DERIVATIVE [J].
DUBROEUCQ, MC ;
BENAVIDES, J ;
DOBLE, A ;
GUILLOUX, F ;
ALLAM, D ;
VAUCHER, N ;
BERTRAND, P ;
GUEREMY, C ;
RENAULT, C ;
UZAN, A ;
LEFUR, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 128 (03) :269-272
[8]
FERRERO P, 1986, P NATL ACAD SCI USA, V83, P7547
[9]
CLONING AND EXPRESSION OF CDNA FOR HUMAN DIAZEPAM BINDING INHIBITOR, A NATURAL LIGAND OF AN ALLOSTERIC REGULATORY SITE OF THE GAMMA-AMINOBUTYRIC-ACID TYPE-A RECEPTOR [J].
GRAY, PW ;
GLAISTER, D ;
SEEBURG, PH ;
GUIDOTTI, A ;
COSTA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) :7547-7551
[10]
ROLE OF DBI IN BRAIN AND ITS POSTTRANSLATIONAL PROCESSING PRODUCTS IN NORMAL AND ABNORMAL-BEHAVIOR [J].
GUIDOTTI, A .
NEUROPHARMACOLOGY, 1991, 30 (12B) :1425-1433